Cefepime shortages continue in 2026. Learn why this critical IV antibiotic is hard to find, what's causing supply issues, and how to locate it.
You or someone you love is fighting a serious infection, and the doctor prescribed Cefepime — a powerful IV antibiotic. But when the hospital pharmacy or infusion center tries to fill the order, they hit a wall: Cefepime is on shortage.
This isn't a minor inconvenience. Cefepime is used for life-threatening infections like pneumonia, urinary tract infections, skin infections, and febrile neutropenia in cancer patients. When it's hard to find, patients and providers scramble for alternatives, often at higher cost or with less ideal coverage.
In this article, we'll explain what Cefepime is, why it's been so difficult to find, and what you can do about it in 2026.
Cefepime (brand name Maxipime) is a fourth-generation cephalosporin antibiotic. It belongs to the beta-lactam class of antibiotics and works by disrupting bacterial cell wall synthesis, which ultimately kills the bacteria causing your infection.
Cefepime is FDA-approved for:
It's administered intravenously (IV) or intramuscularly (IM) in a hospital, infusion center, or through home infusion services. Cefepime is not available as a pill, so access depends entirely on institutional supply chains.
For a deeper dive into the drug itself, check out our guide on what Cefepime is, its uses, and dosage information.
There are several overlapping reasons why Cefepime has been difficult to source in recent years. Here are the main factors driving the shortage:
Cefepime is a sterile injectable medication, which means it must be produced in highly controlled, FDA-inspected manufacturing environments. Any quality control issue — contamination, equipment failure, or a failed FDA inspection — can shut down a production line for months.
B. Braun, one of the major manufacturers of Cefepime injection, has reported shortages due to ongoing manufacturing delays. When one manufacturer goes offline, the remaining suppliers can't always absorb the extra demand.
Sterile injectable antibiotics like Cefepime are produced by only a handful of companies worldwide. Unlike oral medications that dozens of generic companies might produce, the barrier to entry for sterile injectables is high — specialized facilities, rigorous FDA oversight, and thin profit margins discourage new manufacturers from entering the market.
This concentration of production means that a disruption at even one facility can ripple across the entire national supply.
Hospital admissions for serious infections, cancer treatment, and surgical care have continued to grow. As more patients need IV antibiotics, the existing supply gets stretched thinner. Cefepime's versatility — effective against both gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa — makes it a go-to choice for many clinicians, which further increases demand.
Global supply chain challenges have affected pharmaceutical manufacturing broadly. Raw material sourcing, shipping delays, and regulatory bottlenecks in multiple countries have compounded the problem. The sterile injectable supply chain has been particularly vulnerable since the early 2010s, and Cefepime has been caught in these recurring disruptions repeatedly.
For the latest on what's happening with supply, see our Cefepime shortage update for 2026.
If you or your healthcare provider is struggling to find Cefepime, here are some steps that can help:
Medfinder helps patients and providers locate medications that are in stock. Visit medfinder.com to search for Cefepime availability at pharmacies and hospitals near you. This is especially useful for outpatient infusion therapy.
Large chain pharmacies often face the same supply chain bottlenecks. Independent pharmacies and specialty compounding pharmacies may have access to different distributors and could have Cefepime in stock when chains don't.
If Cefepime is genuinely unavailable, your doctor may consider switching to an alternative antibiotic with similar coverage. Options include:
For a full breakdown of alternatives, read our article on alternatives to Cefepime if you can't fill your prescription.
Since Cefepime is typically administered in clinical settings, calling the pharmacy at your hospital or infusion center can give you the most accurate, real-time picture of availability. They may also be able to coordinate with other facilities to source the drug.
For more practical tips, see our guide on how to find Cefepime in stock near you.
Cefepime shortages are frustrating and, frankly, concerning — especially when you or a loved one needs it for a serious infection. The causes are systemic: too few manufacturers, fragile supply chains, and growing demand for a drug that treats some of the most dangerous infections.
The good news is that awareness of these shortages has increased, and tools like Medfinder can help you locate Cefepime faster. If you're a provider navigating this shortage, we also have resources specifically for you — check out our provider guide to the Cefepime shortage.
Stay informed, stay in close contact with your care team, and don't hesitate to advocate for the treatment you need.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
